Evidence map›Paper›PMID 34829576›Full record

ArticleAntioxidants (Basel, Switzerland)2021

New Mutant Amaranth Varieties as a Potential Source of Biologically Active Substances.

Jozef Fejér, Ivan Kron, Adriana Eliašová, Daniela Gruľová, Alena Gajdošová, Veronika Lancíková, Andrea Hricová

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Preliminary evaluation of an extract ofFrontiers in nutrition · 2025
    Article
  3. Does the InvasivePlants (Basel, Switzerland) · 2024
    Article
  4. Total Antioxidant Capacity: Biochemical Aspects and Clinical Significance.International journal of molecular sciences · 2023
    Review
  5. Seasonal Variability ofMolecules (Basel, Switzerland) · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jozef FejérDepartment of Ecology, Faculty of Humanities and Natural Sciences, University of Prešov, 17. Novembra St. 1, 080 01 Prešov, Slovakia.ORCID 0000-0003-0874-5085
Ivan KronJNT Ltd., 040 01 Košice, Slovakia.ORCID 0000-0003-2198-2616
Adriana EliašováDepartment of Ecology, Faculty of Humanities and Natural Sciences, University of Prešov, 17. Novembra St. 1, 080 01 Prešov, Slovakia.
Daniela GruľováDepartment of Ecology, Faculty of Humanities and Natural Sciences, University of Prešov, 17. Novembra St. 1, 080 01 Prešov, Slovakia.
Alena GajdošováInstitute of Plant Genetics and Biotechnology, Slovak Academy of Sciences, Plant Science and Biodiversity Center, Akademická 2, P.O. Box 39A, 950 07 Nitra, Slovakia.
Veronika LancíkováInstitute of Plant Genetics and Biotechnology, Slovak Academy of Sciences, Plant Science and Biodiversity Center, Akademická 2, P.O. Box 39A, 950 07 Nitra, Slovakia.
Andrea HricováInstitute of Plant Genetics and Biotechnology, Slovak Academy of Sciences, Plant Science and Biodiversity Center, Akademická 2, P.O. Box 39A, 950 07 Nitra, Slovakia.

Funding

Ministry of Education, Science, Research and Sport of the Slovak Republic VEGA 1/0087/20
6 · The paper itself

Abstract

Amaranth species represent a diverse group of plants. Many of them are a rich source of secondary metabolites with many positive biological effects. Total phenolic, total flavonoid and rutin content, antioxidant activity against superoxide and hydroxyl radicals, FRAP (Ferric-reducing ability of plasma) assay and DPPH (2,2-Diphenyl-1-picrylhydrazyl) radical scavenging assay were determined in ethanol extracts of dried leaves of the new Slovak amaranth varieties 'Pribina' and 'Zobor'. The amount of total phenolic substances ('Pribina' GAE 38.3 mg.g

Indexed as

Amaranthus cruentus L.Amaranthus hypochondriacus × Amaranthus hybridus L.flavonoidsfree radicalstotal polyphenolsvarieties ‘Pribina’ and ‘Zobor’

Identifiers

PMID34829576
PMCPMC8614743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.